Silver Ronald 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Feb 25, 2026
Research Summary
AI-generated summary of this filing
Ironwood (IRWD) Principal Accounting Officer Ronald Silver Sells Shares
What Happened
Ronald Silver, Principal Accounting Officer of Ironwood Pharmaceuticals (IRWD), sold a total of 24,173 shares of IRWD stock in two transactions on Feb 23–24, 2026. The sales were for tax withholding on vested restricted stock units (automatic "sell-to-cover" transactions), not discretionary trades. Details: 11,552 shares sold on 2026-02-23 at a weighted average price of $3.81 for proceeds of $44,013, and 12,621 shares sold on 2026-02-24 at a weighted average price of $3.66 for proceeds of $46,193 (combined proceeds ≈ $90,206).
Key Details
- Transaction dates & amounts:
- 2026-02-23: 11,552 shares @ weighted avg $3.81 → $44,013 (prices in range $3.70–$4.05; see footnote F2)
- 2026-02-24: 12,621 shares @ weighted avg $3.66 → $46,193 (prices in range $3.60–$3.73; see footnote F3)
- Total shares sold: 24,173; total proceeds ≈ $90,206.
- Purpose: sell-to-cover to satisfy tax withholding on vested restricted stock units (footnote F1); these sales were automatic and not discretionary.
- Filing: Form 4 filed 2026-02-25 covering transactions on Feb 23–24, 2026 — appears to be timely.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote offers: the filer will provide detailed breakdown of number of shares sold at each price within the reported ranges upon request (per F2/F3).
Context
Sell-to-cover transactions are routine when restricted stock units vest and are used solely to meet tax withholding obligations; they do not necessarily indicate the insider’s view on the company’s prospects. The filing reports sales (code S) rather than purchases, so this is not a bullish insider buy signal.
Insider Transaction Report
- Sale
Class A Common Stock
[F1][F2]2026-02-23$3.81/sh−11,552$44,013→ 265,257 total - Sale
Class A Common Stock
[F1][F3]2026-02-24$3.66/sh−12,621$46,193→ 252,636 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.60 to $3.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.